FDA Inspection 1002041 — Adam C. Reynolds, MD
The FDA completed an inspection of Adam C. Reynolds, MD on February 2, 2017 in Eagle, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 2, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Eagle, ID (United States)
Additional Details
Clinical Investigator (CI)